Advanced search
Publication Cover
mAbs Volume 5, 2013 - Issue 1
Submit an article Journal homepage
1,267
Views
13
CrossRef citations to date
0
Altmetric
Meeting Report

American Association of Pharmaceutical Scientists National Biotechnology Conference Short Course: Translational Challenges in Developing Antibody-Drug Conjugates

May 24, 2012, San Diego, CA

Karen Thudium Novartis Pharmaceuticals; Clinical Pharmacology; Oncology Business Unit; Florham Park, NJ USACorrespondence[email protected] [email protected]
,
Sanela Bilic Novartis Pharmaceuticals; Clinical Pharmacology; Oncology Business Unit; Florham Park, NJ USACorrespondence[email protected] [email protected]
,
Douglas Leipold Genentech; South San Francisco, CA USA
,
William Mallet Novartis Institutes for BioMedical Research; Emeryville, CA USA
,
Surinder Kaur Genentech; South San Francisco, CA USA
,
Bernd Meibohm The University of Tennessee Heath Science Center; College of Pharmacy; Memphis, TN USA
,
Hans Erickson ImmunoGen, Inc.; Waltham, MA USA
,
Jay Tibbitts Genentech; South San Francisco, CA USA
,
Hong Zhao U.S. Food and Drug Administration; Silver Spring, MD USA
&
Manish Gupta Bristol-Myers Squibb Company; New Brunswick, NJ USA
 show all
Pages 5-12 | Published online: 19 Dec 2012

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Christopher R Behrens & Bin Liu. (2014) Methods for site-specific drug conjugation to antibodies. mAbs 6:1, pages 46-53.
Read now

Articles from other publishers (12)

Etsuji Kaneko. (2023) Development in Antibody-based Drug Delivery System Technology抗体を活用したドラッグデリバリー技術の開発状況. Drug Delivery System 38:1, pages 49-57.
Crossref
Feroz Jameel, Brittney J. Mills, Ehab M. Moussa, Vikram Sisodiya, Tony Cano & Anthony R. Haight. 2020. Development of Biopharmaceutical Drug-Device Products. Development of Biopharmaceutical Drug-Device Products 27 48 .
Aman P. Singh & Dhaval K. Shah. (2019) A “Dual” Cell-Level Systems PK-PD Model to Characterize the Bystander Effect of ADC. Journal of Pharmaceutical Sciences 108:7, pages 2465-2475.
Crossref
Yoshikatsu Koga, Ryo Tsumura & Yasuhiro Matsumura. 2019. Cancer Drug Delivery Systems Based on the Tumor Microenvironment. Cancer Drug Delivery Systems Based on the Tumor Microenvironment 125 154 .
M. Walles, B. Rudolph, T. Wolf, J. Bourgailh, M. Suetterlin, T. Moenius, G. Peraus, O. Heudi, W. Elbast, C. Lanshoeft & S. Bilic. (2016) New Insights in Tissue Distribution, Metabolism, and Excretion of [3H]-Labeled Antibody Maytansinoid Conjugates in Female Tumor-Bearing Nude Rats. Drug Metabolism and Disposition 44:7, pages 897-910.
Crossref
Yuki Fujiwara, Masaru Furuta, Shino Manabe, Yoshikatsu Koga, Masahiro Yasunaga & Yasuhiro Matsumura. (2016) Imaging mass spectrometry for the precise design of antibody-drug conjugates. Scientific Reports 6:1.
Crossref
Houzong Yao, Feng Jiang, Aiping Lu & Ge Zhang. (2016) Methods to Design and Synthesize Antibody-Drug Conjugates (ADCs). International Journal of Molecular Sciences 17:2, pages 194.
Crossref
Yoshikatsu Koga, Shino Manabe, Yoshiyuki Aihara, Ryuta Sato, Ryo Tsumura, Hikaru Iwafuji, Fumiaki Furuya, Hirobumi Fuchigami, Yuki Fujiwara, Yohei Hisada, Yoshiyuki Yamamoto, Masahiro Yasunaga & Yasuhiro Matsumura. (2015) Antitumor effect of antitissue factor antibody‐MMAE conjugate in human pancreatic tumor xenografts. International Journal of Cancer 137:6, pages 1457-1466.
Crossref
Christina PetersStuart Brown. (2015) Antibody–drug conjugates as novel anti-cancer chemotherapeutics. Bioscience Reports 35:4.
Crossref
Xuejing Yao, Jing Jiang, Xin Wang, Changjiang Huang, Dong Li, Kuan Xie, Qiaoyu Xu, Hongwen Li, Zhuanglin Li, Liguang Lou & Jianmin Fang. (2015) A novel humanized anti-HER2 antibody conjugated with MMAE exerts potent anti-tumor activity. Breast Cancer Research and Treatment 153:1, pages 123-133.
Crossref
Karen J. Cha. 2015. Antibody-Drug Conjugates. Antibody-Drug Conjugates 133 149 .
Dhaval K ShahFrank Barletta, Alison Betts & Steven Hansel. (2013) Key bioanalytical measurements for antibody–drug conjugate development: PK/PD modelers’ perspective. Bioanalysis 5:9, pages 989-992.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.